Evidence map›Paper›PMID 32544527›Full record

ArticleEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V2020

Patchless administration of canine influenza vaccine on dog's ear using insertion-responsive microneedles (IRMN) without removal of hair and its in vivo efficacy evaluation.

In-Jeong Choi, Woonsung Na, Aram Kang, Myun-Hwan Ahn, Minjoo Yeom, Hyung-Ouk Kim, Jong-Woo Lim, Seong-O Choi, Seung-Ki Baek, Daesub Song and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

In-Jeong ChoiQuadMedicine R&D Centre, QuadMedicine, Inc., Seongnam, #605, Building B14 Sagimakgol-ro, 45beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do 13209, Republic of Korea.
Woonsung NaCollege of Veterinary Medicine, Chonnam National University, Yongbong-ro 77, Gwangju 61186, Republic of Korea.
Aram KangCollege of Pharmacy, Korea University, Sejongro 2511, Sejong 30019, Republic of Korea.
Myun-Hwan AhnQuadMedicine R&D Centre, QuadMedicine, Inc., Seongnam, #605, Building B14 Sagimakgol-ro, 45beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do 13209, Republic of Korea.
Minjoo YeomCollege of Pharmacy, Korea University, Sejongro 2511, Sejong 30019, Republic of Korea.
Hyung-Ouk KimDepartment of Biotechnology and Bioengineering, Kangwon National University, Chuncheon, Gangwon-do 24341, Republic of Korea.
Jong-Woo LimDepartment of Chemical and Biomolecular Engineering, Yonsei University Yonsei-ro 50, Seoul 03722, Republic of Korea.
Seong-O ChoiQuadMedicine R&D Centre, QuadMedicine, Inc., Seongnam, #605, Building B14 Sagimakgol-ro, 45beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do 13209, Republic of Korea.
Seung-Ki BaekQuadMedicine R&D Centre, QuadMedicine, Inc., Seongnam, #605, Building B14 Sagimakgol-ro, 45beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do 13209, Republic of Korea.
Daesub SongCollege of Pharmacy, Korea University, Sejongro 2511, Sejong 30019, Republic of Korea. Electronic address: sds1@korea.ac.kr.
Jung-Hwan ParkDepartment of BioNano Technology, Gachon University, Sujeong-gu, Seongnam-si Gyeonggi-do 13120, Republic of Korea. Electronic address: pa90201@gachon.ac.kr.
Korea University · KRChonnam National University · KRGachon University · KRKangwon National University · KRSejong University · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microneedles provide the advantages of convenience and compliance by avoiding the pain and fear of needles that animals often experience. Insertion-responsive microneedles (IRMN) were used for administration to a hairy dog without removing the dog's hair. Canine H3N2 vaccine was administered with IRMN attached to the dog's ears ex vivo and the conventional microneedle system (MN) was administered for 15 min to compare puncture performance and delivery efficiency. The vaccine was also administered to compare antibody formation using IRMN with the use of intramuscular injection. The veterinarian observed the behavior of the dog during the course of the administration and compared the response to IRMN with that of intramuscular administration. The tips of IRMN were separated from the base and delivered into the hairy skin successfully. Puncture performance of IRMN were the same as that of coated microneedles (95%), but delivery efficiency of IRMN were 95% compared to less than 1% for coated microneedles. The H3N2 vaccine inoculated into the dog's ears showed the same antibody formation as the intramuscular injection. The dog appeared to be more comfortable with IRMN administration compared to syringe administration. IRMN are the first microneedle system to deliver a canine vaccine successfully into a hairy dog without removal of the dog's hair. The use of IRMN can provide both convenience and compliance for both the dog and the owner.

Indexed as

Administration, CutaneousAnimalsAntibody FormationDogsDrug Delivery SystemsInfluenza A Virus, H3N2 SubtypeInfluenza VaccinesInjections, IntradermalInjections, IntramuscularMaleNeedlesOrthomyxoviridae InfectionsSkinVaccinationInfluenza VaccinesCanine influenza vaccineComplianceHair removalInsertion-responsive microneedlesLess pain

Identifiers

PMID32544527
PMCPMC7293535
OpenAlexW3035395818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.